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CHAPTER 3 
Fluorescence Detection of Fucosylated Glycans in Neurons 
Introduction 
Glycans are attractive targets for molecular imaging.  As described in Chapter 1, these 
biopolymers have critical roles in many biological processes, and the cellular “glycome” can report on the 
physiological state of the cell.  The ability to visualize these processes in cellular systems would increase 
our understanding of biology and accelerate the development of new clinical tools. However, the 
molecular imaging of glycan structures has been challenging due to their incompatibility with traditional 
imaging methods.  Genetically encoded fluorescent proteins, such as GFP, cannot access specific glycan 
structures.  Though fluorescent antibodies and lectins may have specificity for the glycan of interest, the 
large size of the protein conjugates can restrict their access into intracellular compartments, or perturb the 
localization and natural physiology of the glycan of interest.  Lectin and antibody-based imaging methods 
can provide a snapshot of the glycome at a particular point in time, but are difficult to implement in the 
context of dynamic studies.  Additionally, lectins typically have low affinity for the glycan epitope of 
interest, and require multi-valency for high-avidity binding (1).   
Metabolic labeling with non-natural sugar analogs, followed by bioorthogonal detection 
techniques, fills the need for a chemoselective labeling technique that is compatible with complex cellular 
systems.  Through the selective metabolic incorporation of a bioorthogonal handle, glycans can be tagged 
yet remain functional with the parameters of normal cell activity.  At any point after labeling, these 
glycans can be selectively and sensitively detected using CuAAc or SPAAC, allowing spatial and 
temporal resolution of the metabolically tagged glycans.  For example, sialic acid-containing glycans 
have been visualized using metabolic labeling with sialic acid precursors (e.g. ManNAz or alkynyl-
ManNAc) (2, 3), or sialic acid derivatives (e.g. SiaNaz, or 9-azido Neu5Ac) (4, 5), in a variety of cellular 
systems (3, 6),  as well as in mice and zebrafish in vivo (7, 8).  Mucin-type O-linked glycans have been 
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detected with the metabolic labeling reporter Ac4GalNAz,(9) also in a variety of cellular systems, and 
mice and zebrafish in vivo (8, 10). 
Non-natural fucose analogs have also been used in various cell lines to label and visualize 
fucosylated glycans.  Chi-Huey Wong and coworkers utilized the AlkFuc analog to selectively label 
fucosylated glycoconjugates through the fucose salvage pathway in Hep3B cells and detect them by 
CuAAC labeling using a fluorescent or biotinylated azide (3).  AlkFuc labeled glycoconjugates were 
visualized throughout the cells, with some colocalization with the Golgi marker WGA lectin.  
Additionally, the AlkFuc analog has been used to image fucosylated glycans in the Arabidopsis thaliana 
root cell wall (11), visualizing the localization and targeting of fucosylated glycans in growing cell walls 
and providing insight into the organization and dynamics of the pectin network.  Bertozzi and coworkers 
were able to surmount low levels of metabolic incorporation of the non-natural fucose analogs by 
utilizing the GDP activated derivative of FucAz (GDP-FucAz) to bypass the biosynthetic machinery and 
to metabolically label developing zebrafish embryos in the first five days of development (12). 
Given the biological relevance of fucosylated glycans in neuronal systems (described in Chapter 
1), the fluorescence detection of fucosylated glycoproteins in neurons would have many exciting 
applications.  Fucosylated glycans are reported to be enriched in synapses (13-15), and the cellular 
machinery responsible for protein glycosylation can be found within dendrites (16), raising the possibility 
that local protein synthesis and fucosylation may be occurring at synapses in response to neuronal 
stimulation. Hsieh-Wilson and co-workers have suggested the presence of Fucα(1-2)Gal glycoproteins in 
hippocampal neurons, using the lectin UEAI (17), although their specific subcellular localization remains 
to be determined.  
In order to gain insight into the subcellular localization and dynamics of fucosylated glycans in 
neurons, we sought to develop a protocol using non-natural fucose analogs to image fucosylated glycans 
in neurons.  As the ability to resolve the spatiotemporal dynamics of metabolically labeled fucosylated 
glycans could allow insights into their functional role at synapses, we also sought to develop an assay to 
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investigate the dynamics of glycoproteins within cells and to potentially measure changes in fucosylated 
glycoproteins in response to cellular stimuli or perturbations.  In the following chapter, we describe 
efforts to track the subcellular localization of fucosylated glycoproteins in neurons, and to explore their 
trafficking within the cells. 
Results and Discussion  
We first determined whether the non-natural fucose analogs could be utilized for selectively 
imaging fucosylated proteins in neurons.  Primary rat hippocampal neurons were cultured on coverslips 
and treated with 50 to 100 µM AlkFuc, AzFuc or Fuc in DMSO at 1 DIV.  We observed that the 
hippocampal cultures tolerated 100 µM concentrations of AlkFuc and Fuc with only minimal cytotoxicity, 
whereas AzFuc caused significant cell death.  As a result, the studies described only utilize the AlkFuc 
analog.  After washing out excess molecule, neurons were fixed, permeabilized, and blocked with BSA.   
An additional blocking step with 1 µg/mL streptavidin in BSA was found to be necessary to limit 
background due to fluorescent streptavidin detection.  
Figure 3.1 Fluorescence detection of AlkFuc labeling.  Fuc and AlkFuc labeling (red) in 4 DIV hippocampal 
neurons after metabolic and CuAAC detection.  Nuclei are stained with DAPI (blue).  AlkFuc labeling is apparent 
throughout the soma and processes.  Scale bar is 25 µM. 
The fixed cells were then subjected to CuAAC labeling with azido-biotin.  CuAAC reagents were added 
to a solution of PBS at 25 mM CuSO4, 1 mM sodium ascorbate, 0.05 mM azido-biotin, and 0.05 mM 
triazole ligand, and the reaction mixture was added to each coverslip for an overnight incubation at 4 °C.  
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Subsequent staining with Alexa Fluor 488 conjugated streptavidin revealed extensive fluorescence in the 
cell body, as well as in the neuronal processes, in cells treated with AlkFuc, but not Fuc (Figure 3.1).  In 
order to determine if AlkFuc labeling was specific to glycoproteins, cultures treated with AlkFuc were 
fixed and permeabilized utilizing MeOH to disrupt the lipid membrane, prior to detection with CuAAC 
and Alexa Fluor 488 conjugated streptavidin.  Even after lipid disruption, AlkFuc labeling was still 
apparent throughout the soma and processes, indicating incorporation into glycoproteins (data not shown).  
Thus, we are capable of specifically labeling fucosylated glycoproteins in the cell body as well as along 
the neuronal processes of hippocampal cultures. 
 
Figure 3.2 Subcellular localization of AlkFuc labeling in 4 DIV neurons. AlkFuc labeling (green) was compared 
to the Golgi marker Giantin, an axonal marker Tau, and the dendritic marker MAP2 (red).  AlkFuc labeling 
overlayed strongly with the Golgi marker, and also localized to axons and dendrites.  Scale bar is 25 µM. 
Given that the AlkFuc analog was incorporated into neuronal glycoproteins, we sought to 
determine the subcellular localization of glycans labeled with AlkFuc.  Neurons labeled with AlkFuc were 
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co-stained with the Golgi apparatus marker Giantin, the dendritic marker MAP2, or the axonal marker tau 
(Figure 3.2).  Strong overlay of Alkfuc labeling with the Golgi marker (Figure 3.2, top) indicated the 
localization of AlkFuc labeled proteins to the Golgi apparatus, suggesting that fucosylated glycoproteins 
reside in the Golgi apparatus, consistent with previous results and the notion that fucosylated 
glycoproteins are synthesized in the GA (3, 18).  In addition, we observed labeling of both axons and 
dendrites in 4 DIV neuronal cultures.  Overlay of AlkFuc labeling with both MAP2 and Tau was 
observed, though AlkFuc labeling was stronger in the MAP2 stained dendrites, indicating that the 
AlkFuc-labeled glycoproteins were localized to axons and dendrites (Figure 3.2, middle and bottom).   
For comparison, 14 DIV hippocampal neurons were also co-stained with the lectins Ulex 
europaeus agglutinin I (UEAI), which binds to Fucα(1,2)Gal glycans (19), Lotus tetranoglobus lectin 
(LTL), which binds to α-linked fucose and the Lex and Ley antigens (19), and Anguilla anguilla agglutinin 
(AAA), which binds to Fucα(1-2)Gal structures as well as H antigen types I and II (Figure 3.3) (20).  
UEAI, LTL, and AAA staining showed overlay with a portion of AlkFuc labeling, consistent with AlkFuc 
incorporation into fucosylated glycoproteins recognized by fucose specific lectins.  However, a subset of 
AlkFuc labeling, particularly in the processes, was distinct from the staining of each particular lectin, 
suggesting that the AlkFuc analog labels a broader population of glycans not recognized by the lectins.  
The majority of fucosylated glycans are reported to exist in complex N-linked structures, which can be 
modified by fucose in a variety of linkages.  The ability to label all fucosylated glycans, irrespective of 
linkage, would allow a broader investigation into the role of fucosylated glycans.  
We also examined whether AlkFuc labeling in 14 DIV hippocampal neurons was enriched in 
synapses.  Hippocampal neurons were labeled for 3 d with AlkFuc or Fuc, subsequently fixed, labeled via 
CuAAC, and immunostained with various markers.  As in younger neurons, we observed the strongest 
AlkFuc labeling within the Golgi compartment of mature 14 DIV hippocampal neurons.  In addition, we 
examined the colocalization of AlkFuc to synapses with the synaptic markers synapsin I (pre-synaptic 
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marker), PSD-95 (post-synaptic marker), and spinophilin (post-synaptic marker).  Though there was some 
overlay to synapses indicated by yellow punctae, the majority of AlkFuc labeling was pervasive  
Figure 3.3 AlkFuc labeling when compared to fucose-specific lectins.  AlkFuc labeling (red) in 14 DIV neurons 
compared to the lectins UEAI, LTL, and AAA (green).   
throughout the processes and did not appear to be highly localized to synapses (Figure 3.4), after 3 d of 
labeling.  
In addition to taking a snapshot of fucosylated glycans in the cell at a particular moment, 
metabolic labeling provides the opportunity to track the dynamics of glycoproteins inside cells, affording 
greater insight into changes in subcellular localization in real-time that cannot be obtained using lectins or 
antibodies.  To more closely investigate subcellular dynamics of AlkFuc labeled proteins, we treated 
hippocampal neurons at 4 DIV with a pulse of 200 µM AlkFuc for 1 h and chased with media lacking 
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AlkFuc for increasing periods of time before fixing.  The resulting fluorescence after CuAAC labeling 
with azido-biotin and staining with streptavidin conjugated to Alexa Fluor 488 was observed by confocal 
microscopy.  Until 16 h of incorporation, AlkFuc labeling was largely limited to the Golgi, co-localizing 
with the Golgi marker Giantin (Figure 3.5A), indicating fucosylated glycoproteins were located in the  
Figure 3.4  AlkFuc labeling in 14D IV neurons compared to the synaptic markers PSD-95, syn I, and spinophillin. 
AlkFuc overlay with synaptic markers was not apparent after metabolic labeling for 3 d with the AlkFuc analog. 
Scale bar is 25 µM.  
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Figure 3.5  Pulse-chase analysis of AlkFuc incorporation in 5 DIV neurons.  AlkFuc labeled proteins (red, top row) 
are detected in the Golgi after a 4 to 16 h chase with untreated media when compared to (A) the Golgi marker, 
Giantin, or (B) the neuronal marker β-III tubulin.  Labeled proteins remain largely limited to the Golgi until 16 h 
after incorporation.  Cells treated with a pulse of natural fucose (Fuc) show no labeling.  By 26 h after incorporation, 
AlkFuc labeled glycoproteins are detected in neuronal processes, overlaying with β-III tubulin. Treatment with 2 
µg/mL Brefeldin A (BreA), a protein secretion inhibitor, leads to diffuse AlkFuc labeling with limited labeling in 
neuronal processes. Scale bar is 50 µM. 
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Golgi apparatus (GA).  After a 16 to 26 h chase, AlkFuc labeling was evident throughout the processes, 
overlaying with the cell marker tubulin (Figure 3.5B, arrow), suggesting AlkFuc labeled glycoproteins are 
delivered to neuronal processes after synthesis in the GA.  To validate the conclusion that fucosylated 
glycoproteins are trafficked from the GA to the processes, we added the secretion inhibitor Brefeldin A 
(BreA) was added at various time points after the initial pulse of AlkFuc.  BreA, a lactone isolated from 
fungi, interferes with the transport of proteins from the ER to the Golgi by reversibly disassembling the 
Golgi apparatus (21), and has shown to reversibly inhibit secretory trafficking in neurons (22).  In all 
cases, the addition of BreA disrupted the GA, and AlkFuc labeling was confined to diffuse labeling in the 
soma, with limited labeling in the processes.  Notably, when BreA was added at 16 h after the initial pulse 
of AlkFuc, the majority of AlkFuc labeling in the processes was abolished (Figure 3.5, right panel), 
suggesting that trafficking of AlkFuc labeled glycoproteins occurs 16 h after metabolic incorporation. 
Intrigued by the possibility that fucosylated glycoproteins are enriched in synapses (23), the 
pulse-chase study was repeated in 23 DIV hippocampal neurons with formed synapses.  After 18 h of 
incorporation, labeling was pervasive throughout neuronal processes (Figure 3.6A and 3.6B).  After a 24 h 
chase, AlkFuc labeling manifested as distinct punctae, consistent with synaptic localization of labeled 
fucosylated glycoproteins.  When compared to the pre- and post-synaptic markers synapsin I and GluR1, 
AlkFuc labeling showed significant co-localization with the post-synaptic marker GluR1, suggesting that 
AlkFuc significantly labeled post-synaptic proteins that are delivered to synapses after 36 hours after 
synthesis (Figure 3.6A and 3.6B).  Alternatively, the signal may be the result of a sufficient accumulation  
of synaptic proteins by 36 h; the half-life of synaptic proteins, such as GluR1, have been reported to be 
fairly lengthy, from 1-10 d, depending on the stage of culture and type of neuron (24).  Additional 
examples include NCAM, which has a half-life of 14-20 h in PC12 cells (25), and PSD-95, which has a 
half-life of 24-36 h (26).  The turnover of synaptic glycoproteins has also been reported to be very slow; 
the half-lives of fucose-labeled glycoproteins of synaptic vesicles and the synaptosomal plasma 
membrane were noted to be between 26 and 36 days (27).  As such, the fluorescence may be due to the 
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accumulation of long-lived labeled proteins.  Curiously, we did not detect any labeling in dendrites in the 
early time points, which we might have expected given the discovery of dendritic glycosylation 
machinery (16).  
Figure 3.6.  Pulse-chase analysis of alknyl-fucose incorporation in 23 DIV neurons.  AlkFuc labeled proteins (red, 
top row) are pervasive through the cell body and processes after an 18 h chase. Between 24 h and 36 h after the 
chase, AlkFuc labeled glycoproteins manifest as distinct punctae, and co-localize with pre- and post-synaptic 
markers Syn I (A) and GluR1 (B), suggesting that alknyl-fucose labeled glycoproteins are delivered to the synapses.  
Scale bar is 25 µM except where indicated.  
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Figure 3.6.  Pulse-chase analysis of alknyl-fucose incorporation in 23 DIV neurons.  AlkFuc labeled proteins (red, 
top row) are pervasive through the cell body and processes after an 18 h chase. Between 24 h and 36 h after the 
chase, AlkFuc labeled glycoproteins manifest as distinct punctae, and co-localize with pre- and post-synaptic 
markers Syn I (A) and GluR1 (B), suggesting that alknyl-fucose labeled glycoproteins are delivered to the synapses.  
Scale bar is 25 µM except where indicated.  
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In addition to localization and pulse-chase studies, we were interested in investigating fucosylated 
glycoproteins in response to neuronal stimuli.  In order to determine if AlkFuc labeling was perturbed in 
any way due to neuronal stimulation, hippocampal neurons at 14 DIV were metabolically labeled with 
AlkFuc and depolarized with KCl.  Cultures were labeled with AlkFuc for 2 d prior to a 24 h co-treatment 
with tetrodotoxin (TTX) to ensure neurons were similarly silenced.  AlkFuc labeling in TTX treated 
neurons was consistent with labeling observed thus far:  strong labeling of the Golgi with some labeling 
apparent in neuronal processes (Figure 3.7).  When treated with 50 mM KCl for 6 h, the Golgi was 
observed to fragment as determined by the Golgi marker Giantin, an interesting phenomenon recently 
reported to be caused by neuronal hyperexcitation (28), suggesting that neuronal activity serves as a 
signal to the Golgi.  AlkFuc labeling was similarly diffuse and fragmented in the Golgi as a result of KCl 
depolarization, resulting in punctate labeling throughout the soma and early processes (Figure 3.7, arrow).  
Further studies are necessary to investigate whether neuronal stimulation leads to increased trafficking of 
fucosylated glycoproteins and what implications that may have on neuronal growth and morphology.   
In summary, we are able to track the subcellular localization of AlkFuc glycoproteins in 
hippocampal neurons.  Additionally, we are able to exploit the AlkFuc analog for pulse-chase 
investigations into the dynamic localization of AlkFuc labeled glycoproteins, showing that fucosylated 
glycoproteins are trafficked from the Golgi apparatus and localize to the synapses.  The ability to label 
newly synthesized glycoproteins is a distinct advantage of the metabolic labeling technique over other 
methods, such as lectin staining or chemoenzymatic detection, and could be utilized to study the 
dynamics and trafficking of specific glycoproteins. 
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 Figure 3.7 AlkFuc labeling after KCl depolarization.  After KCl depolarization for 6 h, AlkFuc labeling in the 
Golgi appears diffuse and punctate. Scale bar is 25 µM. 
Experimental Procedures 
Fluorescent Imaging of Fucosylated Glycans in Hippocampal Neurons.  After the indicated 
number of days in culture, hippocampal neurons on coverslips were treated with 50 µM Fuc or AlkFuc for 
3 d. Subsequent to treatment in culture, the media was removed and cells were rinsed once with PBS, 
fixed and permeabilized in ice cold methanol, and washed twice with PBS. All coverslips were blocked in 
3% BSA in PBS for 1 h at rt, followed by 1 µg/mL streptavidin in 3% BSA in PBS for 15 min at rt.  
Metabolically labeled proteins were tagged by treating the cells with 5 mM triazole ligand, 50 mM 
sodium ascorbate (Sigma Aldrich), 50 mM CuSO4 (Sigma Aldrich), and 5 mM alkyne-biotin (CHW lab) 
in PBS (100 µL/coverslip) at 4 °C for 8 h, followed by detection with streptavidin Alexa Fluor 488 (Life 
Untreated 
AlkFuc Golgi Merge 
TTX 
TTX, 6 h KCl  
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Technologies, 1:1000 in 3% BSA).  The primary antibodies anti-synapsin (rabbit, 1:100; Sigma), anti-
PSD-95 (mouse, 1:250; Affinity BioReagents), anti-giantin (Santa Cruz, 1:100), anti-NCAM (mouse, 
1:100, Sigma) and UEAI conjugated to fluorescein (50µL/mL, Sigma) was added in 3% BSA in PBS, 
overnight at 4 °C.  After the coverslips were washed three times with PBS, fluorophore conjugated 
secondary antibodies (goat anti-rabbit; 1:500 and goat anti-mouse; 1:500) were added in 3% BSA in PBS 
for one hour at rt.  AlkFuc was detected with streptavidin-Alexa Fluor 488 (1:1000; Life Technologies) or 
Alexa Fluor 546 (1:1000, Life Technologies) added together with the secondary antibodies. The 
coverslips were washed three times with PBS and mounted onto slides with Vectashield with DAPI 
(Vector Labs) and sealed with clear nail polish. Cells were then subjected to fluorescence and confocal 
microscopy.  
 
Pulse–Chase Analysis of AlkFuc Labeled Proteins.  Hippocampal neurons at 23 DIV were 
treated with 200 µM AlkFuc in supplemented Neurobasal (Invitrogen) for 30 min, after which all the 
media was replaced with alknyl-fucose free media.  Neurons were fixed and permeabilized as described 
above every two to four hours, and stored in PBS at 4 °C  until the termination of the time-course. All 
coverslips were blocked first in  3% BSA in PBS for 1 h at rt, followed by 0.001 µg/µL streptavidin in 3% 
BSA in PBS for 15 min at rt.  Metabolically labeled proteins were tagged by treating the cells 5 mM 
triazole ligand, 50 mM sodium ascorbate (Sigma Aldrich), 50 mM CuSO4 (Sigma Aldrich), and 5 mM 
alkyne-biotin in PBS (100 µL/coverslip)at  4 °C for 8 h, followed by detection with streptavidin Alexa 
Fluor 488 (Life Technologies, 1:1000 in 3% BSA).  Synapsin I, GluR1, and Giantin were detected  and 
the coverslips mounted as described above. Cells were imaged using a 40X or 63X Plan-Achromat 
objective on a Zeiss Meta510 or 700 inverted microscope.  
 
Detection of AlkFuc labeled Proteins after Neuronal Stimulation. After the indicated number 
of days in culture, hippocampal neurons on coverslips were treated with 100 µM Fuc or AlkFuc for 3 d.  2 
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d into the treatment, neuronal cultures were treated with 1 µM tetrodotoxin (TTX; Sigma Aldrich).  After 
1 d of TTX treatment, neurons were stimulated with 50 mM KCl in PBS (Sigma Aldrich) for 5 min up to 
25 h. Subsequent to treatment in culture, the media was removed and cells were rinsed once with PBS, 
fixed and permeabilized in ice cold methanol, and washed twice with PBS. All coverslips were blocked in 
3% BSA in PBS for 1 h at rt, followed by 1 µg/mL streptavidin in 3% BSA in PBS for 15 min at rt.  
Metabolically labeled proteins were tagged by treating the cells 5 mM triazole ligand, 50 mM sodium 
ascorbate (Sigma Aldrich), 50 mM CuSO4 (Sigma Aldrich), and 5 mM alkyne-biotin (CHW lab) in PBS 
(100 µL/coverslip) at 4 °C for 8 h, followed by detection with streptavidin Alexa Fluor 488 (Life 
Technologies, 1:1000 in 3% BSA).  The primary antibodies anti-synapsin (rabbit, 1:100; Sigma), anti-
PSD-95 (mouse, 1:250; Affinity BioReagents), anti-giantin (Santa Cruz, 1:100), anti-NCAM (mouse, 
1:100, Sigma) and UEAI conjugated to fluorescein (50µL/mL, Sigma) was added in 3% BSA in PBS, 
overnight at 4 °C.  After the coverslips were washed three times with PBS, fluorophore conjugated 
secondary antibodies (goat anti-rabbit; 1:500 and goat anti-mouse; 1:500) were added in 3% BSA in PBS 
for one hour at rt.  AlkFuc was detected with streptavidin-Alexa Fluor 488 (1:1000; Life Technologies) or 
Alexa Fluor 546 (1:1000, Life Technologies) added together with the secondary antibodies.  The 
coverslips were washed three times with PBS and mounted onto slides with Vectashield with DAPI 
(Vector Labs) and sealed with clear nail polish.  Cells were then subjected to fluorescence and confocal 
microscopy. 
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